be_ixf;ym_202512 d_30; ct_50
NYSE:BAC charts & data provided by TradingView

Latest Insights on BAC

Wall Street's vaccine rally was a nice diversion, but it’s time to face facts. We still have a long walk down that road to recovery. Retail’s Reality, Tesla’s 500 and Bezos’ Benzos November 17, 2020 by Joseph Hargett Great Stuff Back to Life, Back to Reality I’m rolling with a little late ‘80s hip-pop today. I know that’s not everyone’s cup of tea, but this ‘89 Soul II Soul classic seemed rather appropriate given this morning’s October retail sales data: Back to life, back to the present time, back from a fantasy. The vaccine rally […]
Can you be too cool for the vaccine race? As it turns out, yes you can! With Moderna’s vaccine coming in hot, Pfizer just got one-upped. Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary November 16, 2020 by Joseph Hargett Great Stuff Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]
new normal companies to invest in New COVID-19 Technologies Are Here to Stay November 16, 2020 by Ian King Technology, Winning Investor Daily Although the coronavirus might be a thing of the past by this time next year, technology’s gains are here to stay…
Wall Street’s No. 1 Mistake: Ignoring Long-Term Profits November 16, 2020 by Charles Mizrahi American Investor Today, Education, Investing (4-minute read) A vaccine is on the horizon. Wall Street “experts” are scrambling to take advantage. But they’re focusing on the wrong thing...
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead November 14, 2020 by Jay Goldberg Investment Opportunities, Winning Investor Daily The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This